Netgem SA (EPA:ALNTG)

Aerovate Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	33	32	33	27	48	31
Market Cap Growth	-4.58%	-4.58%	24.01%	-43.85%	53.34%	15.67%
Enterprise Value	27	28	27	25	46	24
Last Close Price	0.97	0.90	0.90	0.79	1.40	0.86
PE Ratio	16.66	16.32	61.76	249.46	-	4.36
Forward PE	-	-	-	-	-	31.54
PS Ratio	0.97	0.94	0.94	0.74	1.70	1.03
PB Ratio	1.31	1.28	1.33	1.13	1.85	1.21
P/TBV Ratio	2.79	2.72	3.03	2.64	8.40	8.81
P/FCF Ratio	11.29	10.98	28.48	47.02	-	-
P/OCF Ratio	4.28	4.16	5.76	3.82	7.45	7.39
EV/Sales Ratio	0.79	0.83	0.76	0.68	1.64	0.79
EV/EBITDA Ratio	3.61	4.14	4.61	4.66	18.42	-
EV/EBIT Ratio	12.55	13.21	81.35	-	-	-
EV/FCF Ratio	9.22	9.70	22.96	43.09	-	-
Debt / Equity Ratio	0.04	0.04	0.08	0.12	0.09	0.32
Debt / EBITDA Ratio	0.13	0.13	0.35	0.54	0.96	-
Debt / FCF Ratio	0.35	0.35	1.72	4.99	-	-
Asset Turnover	0.83	0.83	0.79	0.80	0.60	0.76
Inventory Turnover	8.66	8.66	5.99	9.27	14.02	35.47
Quick Ratio	1.24	1.24	0.93	0.77	0.83	0.88
Current Ratio	1.36	1.36	1.17	1.13	0.96	0.96
Return on Equity (ROE)	7.81%	7.81%	2.83%	-5.29%	-12.77%	19.94%
Return on Assets (ROA)	3.28%	3.28%	0.46%	-2.70%	-4.85%	-9.05%
Return on Capital (ROIC)	5.03%	5.03%	0.77%	-4.47%	-7.39%	-14.11%
Return on Capital Employed (ROCE)	8.20%	8.20%	1.20%	-	-	-
Earnings Yield	5.96%	6.13%	1.62%	0.40%	-2.73%	22.96%
FCF Yield	8.86%	9.11%	3.51%	2.13%	-0.31%	-12.34%
Dividend Yield	5.14%	5.54%	5.56%	6.32%	2.15%	-
Payout Ratio	85.77%	85.77%	270.61%	812.04%	-	-
Buyback Yield / Dilution	1.36%	1.36%	-14.30%	-2.76%	0.44%	-4.04%
Total Shareholder Return	6.57%	6.90%	-8.74%	3.55%	2.59%	-4.04%

Updated Aug 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.